The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the pro… read more
Global X
ETF
Equity
- years
42 holdings
Price
per share adjusted in USD$43.24
Price-1.56%
-$0.69
1Y
Price
Market Cap
$47.337m
Small
$52.506k
Avg VolumeAssets Under Management
$82.180m
$11.02
NAV0.50%
Expense RatioDividends
Ex-Dividend: December 30, 251.39%
Yield$0.60
DividendDividends
Dividend historyNo items found.
Yield
BenchmarkSectors
Top 100 Holdings